(Reuters) – The U.S. Food and Drug Administration approved Eli Lilly and Co’s treatment for severe hypoglycemia, the health regulator said on Wednesday. Hypoglycemia is a condition in which blood sugar falls to dangerously low levels. Severe hypoglycemia typically occurs in people with diabetes who are using insulin treatment, the FDA said and noted that the therapy – Baqsimi – is approved to treat the severe form of the condition in patients with diabetes aged four and older. Full article
(SACRAMENTO) — A Urgent message: Medications can heal, but they can also be deadly. That’s why protocols and controls, supported by rigorous 
and frequent documentation, are needed to reduce the possibility of medication errors in the urgent care setting.
The most recent 10-year study on medical errors by the Institute of Medicine of the National Academies (sponsored by The Centers for Medicare and Medicaid Services) found that medication errors are by far the most common medical errors, harming at least 1.5 million people every year. These medication errors lead to what’s known clinically as adverse drug events (ADE), defined as harm experienced by patients as a result of exposure to a medication. So, the charge for the urgent care leader is, have your staff take a hard look at the medication practices in your center, then answer the question: Is your center part of the problem, or the solution?
Read complete article here in the Journal of Urgent Care Medicine